GlaxoSmithKline (GSK) has unveiled six appointments to the board of Haleon, the consumer healthcare business that will be spun out later this year.

Haleon, which hired ex-Tesco boss Sir Dave Lewis as chairman in December, recruited two of GSK’s non-executive directors – Vindi Banga and Dame Vivienne Cox – as well as three new external hires.

These include Tracy Clarke, a former chief executive at banking giant Standard Chartered, and Deirdre Mahlan, the previous head of North American operations at Guinness owner Diageo.

Split: GlaxoSmithKline has appointed six new directors of its consumer arm Haleon last December

Split: GlaxoSmithKline has appointed six new directors of its consumer arm Haleon last December

Split: GlaxoSmithKline has appointed six new directors of its consumer arm Haleon last December

Also joining is John Young, of US rival Pfizer, which owns around a third of the consumer healthcare business through a joint venture.

Tobias Hestler, the designated chief financial officer of Haleon, will be made an executive director, to join boss Brian McNamara.

Lewis said the appointments will bring ‘considerable board experience’ and the drugs giant plans to add three more directors.

Haleon is due to separate from GSK in July, taking control of GSK’s large portfolio of well-known healthcare brands such as Sensodyne toothpaste. 

It will list in London and is expected to fetch a value of around £45billion.

#fiveDealsWidget .dealItemTitle#mobile {display:none} #fiveDealsWidget {display:block; float:left; clear:both; max-width:636px; margin:0; padding:0; line-height:120%; font-size:12px} #fiveDealsWidget div, #fiveDealsWidget a {margin:0; padding:0; line-height:120%; text-decoration: none; font-family:Arial, Helvetica ,sans-serif} #fiveDealsWidget .widgetTitleBox {display:block; float:left; width:100%; background-color:#af1e1e; } #fiveDealsWidget .widgetTitle {color:#fff; text-transform: uppercase; font-size:18px; font-weight:bold; margin:6px 10px 4px 10px; } #fiveDealsWidget a.dealItem {float:left; display:block; width:124px; margin-right:4px; margin-top:5px; background-color: #e3e3e3; min-height:200px;} #fiveDealsWidget a.dealItem#last {margin-right:0} #fiveDealsWidget .dealItemTitle {display:block; margin:10px 5px; color:#000; font-weight:bold} #fiveDealsWidget .dealItemImage, #fiveDealsWidget .dealItemImage img {float:left; display:block; margin:0; padding:0} #fiveDealsWidget .dealItemImage {border:1px solid #ccc} #fiveDealsWidget .dealItemImage img {width:100%; height:auto} #fiveDealsWidget .dealItemdesc {float:left; display:block; color:#004db3; font-weight:bold; margin:5px;} #fiveDealsWidget .dealItemRate {float:left; display:block; color:#000; margin:5px} #fiveDealsWidget .footerText a:hover{text-decoration: underline;} #fiveDealsWidget .footerSmall{font-size:10px; padding-top:10px;} @media (max-width: 635px) { #fiveDealsWidget a.dealItem {width:19%; margin-right:1%} #fiveDealsWidget a.dealItem#last {width:20%} } @media (max-width: 560px) { #fiveDealsWidget #desktop {display:none;} #fiveDealsWidget #mobile {display:block!important} #fiveDealsWidget a.dealItem {background-color: #fff; height:auto; min-height:auto} #fiveDealsWidget a.dealItem {border-bottom:1px solid #ececec; margin-bottom:5px; padding-bottom:10px} #fiveDealsWidget a.dealItem#last {border-bottom:0px solid #ececec; margin-bottom:5px; padding-bottom:0px} #fiveDealsWidget a.dealItem, #fiveDealsWidget a.dealItem#last {width:100%} #fiveDealsWidget .dealItemContent, #fiveDealsWidget .dealItemImage {float:left; display:inline-block} #fiveDealsWidget .dealItemImage {width:35%; margin-right:1%} #fiveDealsWidget .dealItemContent {width:63%} #fiveDealsWidget .dealItemTitle {margin: 0px 5px 5px; font-size:16px} #fiveDealsWidget .dealItemContent .dealItemdesc, #fiveDealsWidget .dealItemContent .dealItemRate {clear:both} }

This post first appeared on Dailymail.co.uk

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

ALEX BRUMMER: Big pharma’s heroism deserves recognition

The Oxford AstraZeneca Covid-19 vaccine has finally reached the finish line. The…

Britain is better suited to a switch to EVs than any European neighbours

Britain is better suited for a switch to electric cars than any…

Amazon hoping to make up lost ground in its fourth-quarter results

Amazon disappointed investors in its last set of quarterly results when sales…

Cost of Living payment LATEST — First chunk of £900 cash expected to hit Brits’ bank accounts in a matter of weeks

Urgent warning to 820,000 people on Universal Credit Thousands on Universal Credit…